Emergent Biosolutions Stock In The News
| EBS Stock | USD 2.18 0.11 4.80% |
The overall news coverage of Emergent Biosolutions from major news outlets shows solid bullish sentiment on 7 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Emergent Biosolutions' news coverage and content from conventional and social sources shows investors' bearish mood towards Emergent Biosolutions. The specific impact of Emergent Biosolutions news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Emergent Biosolutions' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Emergent Biosolutions headlines in addition to utilizing other, more conventional financial analysis modules. Check out Emergent Biosolutions Backtesting and Emergent Biosolutions Hype Analysis. For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.
Emergent |
Emergent Biosolutions Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Emergent and other traded companies coverage. We help investors stay connected with Emergent headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on Emergent Stock performance. Please note that trading solely based on the Emergent Biosolutions hype is not for everyone as timely availability and quick action are needed to avoid losses.Emergent Biosolutions stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Emergent earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Emergent Biosolutions that are available to investors today. That information is available publicly through Emergent media outlets and privately through word of mouth or via Emergent internal channels. However, regardless of the origin, that massive amount of Emergent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Emergent Biosolutions news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Emergent Biosolutions relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Emergent Biosolutions' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Emergent Biosolutions alpha.
Emergent Largest EPS Surprises
Earnings surprises can significantly impact Emergent Biosolutions' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2009-11-05 | 2009-09-30 | 0.06 | 0.03 | -0.03 | 50 | ||
2009-03-05 | 2008-12-31 | 0.02 | 0.05 | 0.03 | 150 | ||
2008-05-07 | 2008-03-31 | 0.27 | 0.24 | -0.03 | 11 | ||
2012-11-01 | 2012-09-30 | 0.14 | 0.18 | 0.04 | 28 | ||
2022-04-28 | 2022-03-31 | 0.13 | 0.18 | 0.05 | 38 | ||
2019-08-01 | 2019-06-30 | 0.17 | 0.12 | -0.05 | 29 |
Emergent Biosolutions Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Emergent Biosolutions Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
22nd of April 2024
Emergent BioSolutions to Release First Quarter 2024 Financial Results Conduct Conference C... at finance.yahoo.com
15th of April 2024
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.s recent 11 pe... at simplywall.st
5th of April 2024
Assenagon Asset Management S.A. Buys 651,480 Shares of Emergent BioSolutions Inc. - Market... at news.google.com
28th of March 2024
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN Na... at globenewswire.com
25th of March 2024
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility at benzinga.com
13th of March 2024
Acquisition by William Hartzel of 125000 shares of Emergent Biosolutions at 2.33 subject t... at MacroaxisInsider
7th of March 2024
Q4 2023 Emergent BioSolutions Inc Earnings Call Transcript at gurufocus.com
6th of March 2024
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results at finance.yahoo.com
21st of February 2024
Why Is Emergent BioSolutions Stock Up 70 percent Today at investorplace.com
Emergent Biosolutions Investors Sentiment
The influence of Emergent Biosolutions' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Emergent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with an investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Emergent Biosolutions.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emergent Biosolutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emergent Biosolutions' short interest history, or implied volatility extrapolated from Emergent Biosolutions options trading.
Check out Emergent Biosolutions Backtesting and Emergent Biosolutions Hype Analysis. For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Emergent Stock analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Earnings Share (14.85) | Revenue Per Share 20.494 | Quarterly Revenue Growth (0.16) | Return On Assets (0.05) |
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if Emergent Biosolutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.